Product Information
LAMIVUDINE-ZIDOVUDINE TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.6918 per EA under NDC 33342000309. Its NADAC has been published 372 times since May 15, 2019.
Strength
150; 300 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342000309
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMIVUDINE; ZIDOVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA090679On Market Since
8/30/2018
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE-ZIDOVUDINE TABLET has been published 372 times since May 15, 2019, and over the history we have for it it has declined 26.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6918 per EA |
|---|---|
| All-time high | $1.8425 (Oct 16, 2019) |
| All-time low | $0.5570 (Jan 21, 2026) |
| 52-week high | $0.7148 |
| 52-week low | $0.5570 |
| Median price | $0.7530 |
| Average price | $0.8367 |
| Largest weekly change | +57.7% (Aug 21, 2019) |
| Weeks tracked | 372 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE-ZIDOVUDINE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE-ZIDOVUDINE TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.6918 per EA (NDC 33342000309), effective Jun 24, 2026.
How has the price of LAMIVUDINE-ZIDOVUDINE TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE-ZIDOVUDINE TABLET has declined 26.7%. It has been tracked across 372 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE-ZIDOVUDINE TABLET?
Since May 15, 2019, the NADAC for LAMIVUDINE-ZIDOVUDINE TABLET has ranged from a low of $0.5570 (Jan 21, 2026) to a high of $1.8425 (Oct 16, 2019), with a median of $0.7530 per EA.
Are there cheaper alternatives to LAMIVUDINE-ZIDOVUDINE TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as LAMIVUDINE-ZIDOVUDINE TABLET, but none are currently priced below it.
Who manufactures LAMIVUDINE-ZIDOVUDINE TABLET?
LAMIVUDINE-ZIDOVUDINE TABLET (NDC 33342000309) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification